Trials / Completed
CompletedNCT01923584
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EPI-743 400mg | |
| DRUG | EPI-743 200mg |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-12-01
- Completion
- 2016-06-01
- First posted
- 2013-08-15
- Last updated
- 2016-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01923584. Inclusion in this directory is not an endorsement.